Empagliflozin and linagliptin and NovoLog Mix 70/30
Determining the interaction of Empagliflozin and linagliptin and NovoLog Mix 70/30 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: empagliflozin / linagliptin
Brand name: Glyxambi
Synonyms: Empagliflozin and Linagliptin
Generic Name: insulin aspart / insulin aspart protamine
Brand name: NovoLog Mix 70/30, NovoLog Mix 70/30 FlexPen, NovoLOG Mix 70/30 PenFill
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Empagliflozin and linagliptin-NovoLog Mix 70/30 (Insulin Aspart Protamine and Insulin Aspart (Cartridges and Prefilled Pens))
- Empagliflozin and linagliptin-NovoLog Mix 70/30 (Insulin Aspart Protamine and Insulin Aspart (Vials))
- Empagliflozin and linagliptin-NovoLog Mix 70/30 FlexPen
- Empagliflozin and linagliptin-NovoLog PenFill
- Empagliflozin and linagliptin-Novoseven
- Empagliflozin and linagliptin-NovoSeven RT
- NovoLog Mix 70/30-Empagliflozin and metformin
- NovoLog Mix 70/30-Empagliflozin and Metformin Extended-Release Tablets
- NovoLog Mix 70/30-Empagliflozin and Metformin Tablets
- NovoLog Mix 70/30-Empliciti
- NovoLog Mix 70/30-Emsam
- NovoLog Mix 70/30-Emsam Transdermal